According to a recent Growth Plus Reports study, the global e-prescribing market is estimated to hit US$ 10.32 billion by 2030, with a revenue CAGR of 23.90%. The study examines the important strategies, drivers and prospects, competitive circumstances, shifting market dynamics, market size, data and forecasts, and important investment regions.
Key Takeaways:
- The increasing prevalence of chronic diseases and viruses will drive market revenue growth.
- Increasing adoption of EHR will drive demand for e-prescribing.
- North America dominates the global e-prescribing market.
Request a Free Sample Copy of the Research Report: https://www.growthplusreports.com/inquiry/request-sample/e-prescribing-market/7883
E-prescribing Market Scope
| Report Attribute | Details |
| Market size value in 2021 | US$ 1.5 billion |
| Revenue forecast in 2030 | US$ 10.32 billion |
| Growth Rate | CAGR of 23.9% from 2022 to 2030 |
| Base year for estimation | 2021 |
| Forecast period | 2022-2030 |
| Segments covered | Component, Mode of Delivery, End-User, and Region. |
| Regional scope | North America, Europe, Asia Pacific, and the Rest of the World (ROW) |
Market Drivers
The increasing prevalence of chronic diseases will drive the revenue growth of the e-prescribing market. Furthermore, the rising geriatric population and urbanization are expected to boost the market revenue growth. The increasing government support and funding, rising EHR (electronic health record) adoption, decreasing medical costs, increased emphasis on reducing medical errors, and growing use of telemedicine/telehealth is expected to support the market’s revenue growth.
Market Segmentation
Growth Plus Reports has analyzed the global e-prescribing market from four perspectives: Component, Mode of Delivery, End-User, and Region.
Component Segmentation: Based on the component, the global e-prescribing market is segmented into software and services. The services segment dominates the market with the largest revenue share because e-prescribing is becoming increasingly popular, with strict rules for validating and verifying hardware and software and the need for support and maintenance.
Mode of Delivery Segmentation: Based on the mode of delivery, the global e-prescribing market is segmented into on-cloud and on-premise delivery. The on-cloud delivery segment dominates the market because of its large customer base and advantages such as flexibility, scalability, better productivity, security, faster and convenient software implementation, timely access, and a simple interface.
End-User Segmentation: Based on the end-user, the global e-prescribing market is segmented into hospitals, clinics, and pharmacies. The hospital segment dominates the market due to the large patient footfall. The pharmacy segment accounts for the second-largest revenue share due to the large patient base.
Request for Customization – https://www.growthplusreports.com/inquiry/customization/e-prescribing-market/7883
Regional Growth Dynamics
Based on the region, the global e-prescribing market is segmented into North America, Europe, Asia Pacific, and the Rest of the World.
North America dominates the global e-prescribing market with the largest revenue share. The presence of a large patient pool, high prevalence of chronic diseases, increasing geriatric population, high healthcare expenditure, rapid adoption of advanced technologies, increased government initiatives & investments/funding, and advanced healthcare infrastructure are the major factors responsible for North America’s significant revenue share in the global market.
Competitive Landscape
The key players in the global e-prescribing market are:
- Cerner Corporation
- Practice Fusion Inc.
- Allscripts Healthcare Solutions Inc.
- Epic Systems Corporation
- Athenahealth Inc.
- eClinicalWorks
- Medical Information Technology Inc.
- GE Healthcare
- McKesson Corporation
- DrFirst Inc.
- Henry Schein Inc.
- Networking Technology Inc. (RXNT)
- Surescripts-RxHub LLC
- NextGen Healthcare
The market for e-prescribing is highly competitive, with few key players. Major competitors use technological advancements, R&D, mergers, and acquisitions to strengthen their market position.
Recent developments:
- FDB Vela, a new cloud-native e-prescribing network that enables the seamless flow of critical medication prescription information, benefits verification, and clinical decision support between prescribers, payers, pharmacies, and other constituents, was launched in March 2022 by FDB (First Databank, Inc.).
- Meddo, an Indian firm that operates a digital outpatient care platform, paid cash and stocks to acquire Doxper in August 2021. The deal will add 300,000 to 400,000 new patients to Meddo’s monthly client base. The purchase also aims to transform 1,000 additional clinics in top-tier Indian markets.
Table of Content
- INTRODUCTION
- Market Ecosystem
- Timeline Under Consideration
- Historical Years – 2020
- Base Year – 2021
- Forecasted Years – 2022 to 2030
- Currency Used in the Report
- RESEARCH METHODOLOGY
- Research Approach
- Data Collection Methodology
- Data Sources
- Secondary Sources
- Primary Sources
- Market Estimation Approach
- Bottom Up
- Top Down
- Market Forecasting Model
- Limitations and Assumptions
- PREMIUM INSIGHTS
- Current Market Trends (COVID-19 Perspective)
- Key Players & Competitive Positioning (2021)
- MARKET DYNAMICS
- Drivers
- Restraints
- Opportunities
- GLOBAL E-PRESCRIBING MARKET- ANALYSIS & FORECAST, BY COMPONENT
- Software
- Services
- GLOBAL E-PRESCRIBING MARKET- ANALYSIS & FORECAST, BY MODE OF DELIVERY
- On-cloud Based Delivery
- On-premise Based Delivery
- GLOBAL E-PRESCRIBING MARKET- ANALYSIS & FORECAST, BY END-USER
- Hospitals
- Clinics
- Pharmacies
Buy this Premium Research Report: https://www.growthplusreports.com/checkout-7883
VALUE PROPOSITIONS RELATED TO THE REPORT:
- Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
- Comprehensive quantitative and qualitative insights at segment and sub-segment level
- Covid 19 impact trends and perspective
- Granular insights at global/regional/country level
- Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
- Blanket coverage on competitive landscape
- Winning imperatives
- Exhaustive coverage on ‘Strategic Developments’ registered by leading players of the market
CUSTOMIZATION OPTIONS:
- Distributor Landscape Assessment
- Pricing Intelligence
- Customer Base Assessment
- Investment & Initiatives Analysis
- ‘Business Profile’ of Key Players
Schedule a call with our analyst: https://appoint.ly/s/salesZ3Jvd3RocGx1c3JlcG9ydHMuY29t/introduction
Visit our report store at – https://www.growthplusreports.com/report-store
Browse related reports:
Sequencing Reagents Market by Technology (Next-Generation Sequencing, Third-Generation Sequencing), Type (Sequencing Kits, Library Kits), Application (Oncology), End User (Academic Research, Hospitals & Clinics)– Global Outlook & Forecast 2023-2031
Regulatory Writing Market by Type (Investigator Brochures, Case Report Forms), End User (Contract Research Organizations, Pharmaceutical & Biotechnological Companies) – Global Outlook & Forecast 2023-2031
Pneumatic Compression Therapy Market by Product (Compression Pumps, Compression Garments), Technique (Dynamic Compression Therapy, Static Compression Therapy), and Application (Deep Vein Thrombosis, Varicose Veins) – Global Outlook & Forecast 2023-2031
Nutraceuticals Market by Types (Dietary Supplements, Functional Foods & Beverages), Distribution Channel (Conventional Stores, Specialty Stores, Online Retailers) – Global Outlook and Forecast 2023-2031
Microbiome Therapeutics Market by Type (Fecal Microbial Transplant, Microbiome Drugs), Application (C. difficle, Crohn’s Disease, Inflammatory Bowel Disease, Diabetes) – Global Outlook & Forecast 2023-2031
About Us:
Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).
Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.
We were awarded by the prestigious CEO Magazine as “Most Innovative Healthcare Market Research Company in 2020.
Contact:
Manan Sethi
Director, Market Insights
Email: sales@growthplusreports.com
256 Chapman Road
STE 105-4, Newark,
New Castle – 19702, USA
Phone no: +1 888 550 5009
Web: https://www.growthplusreports.com/